FDA Inspection 675139 — The Mount Sinai Hospital

The Mount Sinai Hospital — FEI 2470025

The FDA completed an inspection of The Mount Sinai Hospital on Aug 17, 2010 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 17, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
154021 CFR 211.125(a)Strict control not exercised over labeling issued
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
22721 CFR 640.4(h)Storage temperatures after collection
8121 CFR 606.100(b)(2)Donor qualifying tests & measurements
922021 CFR 606.100(b)(21)Donor notification
922521 CFR 606.171Biological product deviation report
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.